Shree Ganesh Biotech India Ltd

Shree Ganesh Biotech India Ltd (SHREEGANES) is a micro-cap Healthcare company valued at ₹18 crore operating in Biotechnology on the NSE and BSE.

Recent price move

Shree Ganesh Biotech India Ltd last traded at ₹0.46, unchanged on the day.

Recent developments

On 2026-06-30, the company reported a net profit loss of ₹1 crore for the latest quarter, compared to a net profit of ₹0 crore in the same quarter a year earlier. This marks a significant shift in the company's financial performance.

Financial performance

The company's business is shrinking, with annual revenue falling 78.4% year-over-year. The latest quarter saw revenue rise 3.6% compared to the same quarter a year earlier, but net profit swung from a profit of ₹0 crore to a loss of ₹1 crore, showing a sharp deterioration in profitability.

Valuation multiples

The stock trades at 46.0 times earnings, a premium to the Healthcare median of 32.0, 0.31 times book value.

Things to watch

The company's net profit fell to a loss of ₹1 crore in the latest quarter, compared to a profit of ₹0 crore in the same quarter a year earlier. The stock is 38.7% below its 52-week high, indicating a substantial decline in value.

Where it stands

The company's financial performance has deteriorated sharply, with a net profit loss of ₹1 crore in the latest quarter. The stock is 38.7% below its 52-week high, reflecting a significant drop in value.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.